| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Articles |
Commercially available immune assays are being used with increasing frequency in the study of lung inflammation. However, their performance in complex biological fluids is rarely assessed. The authors wished to assess their reliability to determine whether the results obtained in sputum samples can be easily interpreted. The reproducibility of several such assays was therefore determined together with their ability to recover known amounts of pure reagent. Sputum sol phase was obtained from several patients with chronic lung disease and used together with the reagents in a series of "spiking" and dilutional experiments. Results confirmed that the enzyme assay for myeloperoxidase and the immune assays for interleukin-8, leukotriene B4 and secretory leukoproteinase inhibitor were all reproducible (intra-assay coefficient of variation 3.8-7.7%). Furthermore, each of these assays gave >85% recovery of a "spike" with pure reagent. However, the immune assay for myeloperoxidase (although reproducible) gave poor recovery and was dependent on the degree of sample dilution and elastase content. These studies confirm that the reliabilities of fluid phase measurements should be assessed before being widely applied to complex biological samples.
This article has been cited by other articles:
|
|
 |
|
  E. Sapey, D. Bayley, A. Ahmad, and R. Stockley The validation of assays used to measure biomarkers in exhaled breath condensate Eur. Respir. J., November 1, 2008; 32(5): 1408 - 1409. [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bayley, H. Abusriwil, A. Ahmad, and R. A. Stockley Validation of assays for inflammatory mediators in exhaled breath condensate Eur. Respir. J., May 1, 2008; 31(5): 943 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Erin, G. R. Jenkins, O. M. Kon, A. S. Zacharasiewicz, G. C. Nicholson, H. Neighbour, R. C. Tennant, A. J. Tan, B. R. Leaker, A. Bush, et al. Optimized Dialysis and Protease Inhibition of Sputum Dithiothreitol Supernatants Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 132 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Cianchetti, E. Bacci, L. Ruocco, M.L. Bartoli, M. Ricci, T. Pavia, F.L. Dente, A. Di Franco, B. Vagaggini, and P.L. Paggiaro Granulocyte markers in hypertonic and isotonic saline-induced sputum of asthmatic subjects Eur. Respir. J., December 1, 2004; 24(6): 1018 - 1024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Banerjee, O.A. Khair, and D. Honeybourne Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD Eur. Respir. J., May 1, 2004; 23(5): 685 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ahmad, D. L. Bayley, S. He, and R. A. Stockley Myeloid Related Protein-8/14 Stimulates Interleukin-8 Production in Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., October 1, 2003; 29(4): 523 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J White, S Gompertz, D L Bayley, S L Hill, C O'Brien, I Unsal, and R A Stockley Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis Thorax, August 1, 2003; 58(8): 680 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Beeh, J. Beier, O. Kornmann, A. Mander, and R. Buhl Long-term Repeatability of Induced Sputum Cells and Inflammatory Markers in Stable, Moderately Severe COPD Chest, March 1, 2003; 123(3): 778 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I S Woolhouse, D L Bayley, and R A Stockley Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis Thorax, August 1, 2002; 57(8): 667 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I S Woolhouse, D L Bayley, and R A Stockley Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of {alpha}1-antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 Thorax, August 1, 2002; 57(8): 709 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gompertz and R. A. Stockley A Randomized, Placebo-Controlled Trial of a Leukotriene Synthesis Inhibitor in Patients With COPD* Chest, July 1, 2002; 122(1): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Leader of the Working Group: M.M. Kelly, Members of the Working Group:, V. Keatings, R. Leigh, C. Peterson, J. Shute, P. Venge, and R. Djukanovic Analysis of fluid{-}phase mediators Eur. Respir. J., July 1, 2002; 20(37_suppl): 24S - 39s. [Full Text] [PDF]
|
|
|
|
|
|
S. Gompertz, C. O'Brien, D.L. Bayley, S.L. Hill, and R.A. Stockley Changes in bronchial inflammation during acute exacerbations of chronic bronchitis Eur. Respir. J., June 1, 2001; 17(6): 1112 - 1119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hill, S. Gompertz, and R. Stockley Factors influencing airway inflammation in chronic obstructive pulmonary disease Thorax, November 1, 2000; 55(11): 970 - 977. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
